Related references
Note: Only part of the references are listed.2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino et al.
EUROPEAN HEART JOURNAL (2020)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
N-terminal Pro B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin as Markers for Heart Failure and Cardiovascular Disease Risks According to Glucose Status (from the Multi-Ethnic Study of Atherosclerosis [MESA])
Khoa Nguyen et al.
AMERICAN JOURNAL OF CARDIOLOGY (2020)
Biomarker-defined pathways for incident type 2 diabetes and coronary heart disease-a comparison in the MONICA/KORA study
Cornelia Huth et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial
Abhinav Sharma et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus
Marcus V. B. Malachias et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Amino-Terminal Pro-B-Type Natriuretic Peptide Implications for Cardiovascular Risk Reduction
James L. Januzzi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes
Rasmus Rorth et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus
Yuen-Kwun Wong et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017
Thomas R. Einarson et al.
CARDIOVASCULAR DIABETOLOGY (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
Serotonin improves glucose metabolism by Serotonylation of the small GTPase Rab4 in L6 skeletal muscle cells
Ramona Al-Zoairy et al.
DIABETOLOGY & METABOLIC SYNDROME (2017)
Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
Emil Wolsk et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender
Piercarlo Ballo et al.
CLINICAL RESEARCH IN CARDIOLOGY (2016)
Diabetes and Prior Coronary Heart Disease are Not Necessarily Risk Equivalent for Future Coronary Heart Disease Events
Jamal S. Rana et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2016)
Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction Insights From the PARADIGM-HF Study (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial)
Wilson Nadruz et al.
CIRCULATION (2016)
Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
Mauro Gori et al.
DIABETES CARE (2016)
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo F. Piepoli et al.
EUROPEAN HEART JOURNAL (2016)
Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk A Secondary Analysis of a Randomized Clinical Trial
Benjamin M. Scirica et al.
JAMA CARDIOLOGY (2016)
Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes
Bernt Johan von Scholten et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes
Helen C. Looker et al.
DIABETOLOGIA (2015)
The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes
Graham S. Hillis et al.
DIABETES CARE (2014)
N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study
Anna H. Price et al.
DIABETOLOGIA (2014)
Natriuretic Peptide-Based Screening and Collaborative Care for Heart Failure The STOP-HF Randomized Trial
Mark Ledwidge et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
PONTIAC (NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease)
Martin Huelsmann et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Cost-Effectiveness of N-Terminal Pro-B-Type Natriuretic-Guided Therapy in Elderly Heart Failure Patients Results From TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure)
Sandra Sanders-van Wijk et al.
JACC-HEART FAILURE (2013)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
N. Sarwar et al.
LANCET (2010)
Is diabetes a coronary risk equivalent? Systematic review and meta-analysis
U. Bulugahapitiya et al.
DIABETIC MEDICINE (2009)
Cardiovascular risk assessment scores for people with diabetes: a systematic review
P. Chamnan et al.
DIABETOLOGIA (2009)
The Role of N-terminal PRO-Brain Natriuretic Peptide and Echocardiography for Screening Asymptomatic Left Ventricular Dysfunction in a Population at High Risk for Heart Failure. The PROBE-HF Study
Irene Betti et al.
JOURNAL OF CARDIAC FAILURE (2009)
NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus
Martin Huelsmann et al.
EUROPEAN HEART JOURNAL (2008)
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2008)
Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes
Ruth L. Coleman et al.
DIABETES CARE (2007)
Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea
Antoni Bayes-Genis et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Major risk factors as antecedents of fatal and nonfatal coronary heart disease events
P Greenland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project
RM Conroy et al.
EUROPEAN HEART JOURNAL (2003)
The relation of atherosclerotic cardiovascular disease to retinopathy in people with diabetes in the Cardiovascular Health Study
R Klein et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)
Characteristics of an adult population with newly diagnosed type 2 diabetes - The relation of obesity and age of onset
TA Hillier et al.
DIABETES CARE (2001)
Share Paper
